Simone Battella

Rome, 00128, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory Approach.

Non-Clinical Safety of GRAd Vector-Based COVID-19 and HIV Vaccines Supports a Platform Regulatory Approach.

Journal: Vaccines

Published: January 09, 2026

Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.

Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.

Journal: Frontiers in immunology

Published: April 03, 2023

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.

GRAd-COV2 vaccine provides potent and durable humoral and cellular immunity to SARS-CoV-2 in randomized placebo-controlled phase 2 trial.

Journal: Cell reports. Medicine

Published: October 21, 2022

Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.

Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature.

Journal: Frontiers in immunology

Published: September 13, 2022

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.

Safety and immune response kinetics of GRAd-COV2 vaccine: phase 1 clinical trial results.

Journal: NPJ vaccines

Published: February 18, 2022

(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition.

(Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition.

Journal: Biomedicines

Published: February 14, 2022

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.

GRAd-COV2, a gorilla adenovirus-based candidate vaccine against COVID-19, is safe and immunogenic in younger and older adults.

Journal: Science translational medicine

Published: October 26, 2021

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs.

Journal: Cancers

Published: April 27, 2021

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.

Immunogenicity of a new gorilla adenovirus vaccine candidate for COVID-19.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: December 06, 2020

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis.

CD16 pre-ligation by defucosylated tumor-targeting mAb sensitizes human NK cells to γc cytokine stimulation via PI3K/mTOR axis.

Journal: Cancer immunology, immunotherapy : CII

Published: September 19, 2019

Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).

Fine tuning of the DNAM-1/TIGIT/ligand axis in mucosal T cells and its dysregulation in pediatric inflammatory bowel diseases (IBD).

Journal: Mucosal immunology

Published: June 13, 2019

Memory NK Cell Features Exploitable in Anticancer Immunotherapy.

Memory NK Cell Features Exploitable in Anticancer Immunotherapy.

Journal: Journal of immunology research

Published: October 05, 2018

Showing 1-12 of 23

Last Updated: 09/26/2026